Bravecto (Fluralaner) Topical Solution for Dogs is an FDA-Approved medication that kills adult fleas. It treats and prevents of flea infestations (Ctenocephalides felis) and also treats and controls several types of tick infestations for 12 weeks. These include:
Bravecto Topical Solution for Dogs also treats and controls of Amblyomma americanum (lone star tick) infestations for 8 weeks.
Bravecto Topical Solution for Dogs is used to treat and control flea and tick infestations.
Dogs over 6 months of age and weighing over 4.4 pounds.
Bravecto Topical Solution for Dogs releases the active ingredient, fluralaner, throughout the dog's body. Fluralaner
Bravecto should be administered topically as a single dose every 12 weeks according to the Dosage Table below to provide a minimum dose of 11.4 mg/lb (25 mg/kg) body weight.Bravecto may be administered every 8 weeks in case of potential exposure to Amblyomma americanumticks (see Effectiveness).
|Body Weight Ranges (lb)||Fluralaner Content (mg)/tube||Tubes Administered|
Dogs over 123.0 lbs should be administered the appropriate combination of tubes.
Do not store above 77°F (25°C). Store in the original package in order to protect from moisture. The pouch should only be opened immediately prior to use.
There are no known contraindications for the use of the product.
Not for human use. Keep this and all drugs out of the reach of children.
Do not contact or allow children to contact the application site until dry.
Keep the product in the original packaging until use in order to prevent children from getting direct access to the product. Do not eat, drink or smoke while handling the product. Avoid contact with skin and eyes. If contact with eyes occurs, then flush eyes slowly and gently with water. Wash hands and contacted skin thoroughly with soap and water immediately after use of the product.
The product is highly flammable. Keep away from heat, sparks, open flame or other sources of ignition.
For topical use only. Avoid oral ingestion..
Use with caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures.
Bravecto has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Bravecto is not effective against Amblyomma americanum ticks beyond 8 weeks after dosing.
Vomiting, alopecia, diarrhea, lethargy, decreased appetite, moist dermatitis/rash.